Senotherapeutics, Aging, and Age-Related Diseases
2024
Senotherapeutics and Aging
publication
Author Information
Author(s): Kellogg Dean
Primary Institution: The University of Texas Health Science Center San Antonio
Hypothesis
Can senotherapeutic agents effectively intervene in aging and age-related diseases?
Conclusion
Senolytic and senomorphic drugs are safe for older individuals and show promise for treating age-related diseases.
Supporting Evidence
- Numerous pre-clinical trials support the rationale for human clinical trials.
- New human clinical trials are being proposed to test efficacy in older individuals.
Takeaway
Scientists are testing new medicines that might help older people feel better and live longer.
Methodology
Review of pre-clinical and proposed human clinical trials on senotherapeutic agents.
Participant Demographics
Older persons
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website